- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Molecular Imaging Resources
Biomarkers in Imaging: Realizing Radiology's Future
(Radiology 2003;227:633-648) Opinion piece by Dr. John J. Smith, Dr. A. Gregory Sorensen, and Dr. James Thrall of Massachusetts General Hospital that argues for biomarker imaging as a strategy to improve diagnosis and monitor therapeutic response.
National Cancer Institute: a plan and budget proposal for fiscal year 2005
Molecular imaging figures prominently in the NCI's 2005 budget. The surprisingly readable 134-page document is a benchmark for the status and funding of cancer research.
Synarc
(www.synarc.com/services/therapeutic-areas/ oncology/classesbiomarkers.html)
This commercial site features an insightful primer on the role of biomarkers in imaging, oncology, and orthopedic medicine. Synarc is a central radiology service dedicated to global clinical trials. Its founders include Dr. Harry Genant, Dr. Charles Peterfy, and other musculoskeletal radiologists associated with the University of California, San Francisco.
Industry Watch: Medical Imaging Drug Discovery
Online posting of an article from the March/April 2004 issue of PharmaGenomics offers a straightforward assessment of the imaging of biomarkers as a tool for pharmaceutical R&D.
Massachusetts General Hospital Center for Biomarkers in Imaging
You can join the center, which uses imaging biomarkers to accelerate the pace of drug development. It seeks members in government, academia, industry, and the general community. Participation offers radiologists access to the latest developments in imaging biomarkers and their application in molecular imaging. The site features a detailed catalog of biomarkers that can be sorted by disease, disease category, and author.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
